Intensity Therapeutics, Inc. INTS 深 滬
等待開盤 12-18 09:30:00 美东时间
0.4285
-0.011
-2.50%
華盛通- 最 高0.4629
- 今 開0.458
- 成交量 155.42万股
- 最 低 0.4206
- 昨 收 0.4395
- 總市值 2573.79万
- 52周最高 3.1663
- 市盈率 靜 --
- 換手率 2.59%
- 52周最低 0.1853
- 委 比 -88.68%
- 總股本 6006.50万
- 歷史最高 11.44
- 量 比 0.76
- 振 幅 9.62%
- 歷史最低 0.1853
- 每 手 1
- 風險率 0.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intensity Therapeutics Has Been Granted U.S. Patent Number 12,496,345 Titled "Method of treating cancer"
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12496345).pn
12-17 05:04
Intensity Therapeutics Granted 180-Day Extension To Regain Nasdaq Compliance
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (NASDAQ:INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to
12-05 20:31
Intensity Therapeutics shares are trading higher after the company announced two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium.
Intensity Therapeutics shares are trading higher after the company announced tw...
12-04 22:03
Intensity Therapeutics Expands At-The-Market Offering
Intensity Therapeutics, Inc. ( ($INTS) ) has shared an announcement. On Decembe...
12-04 20:29
Intensity Therapeutics Enters Securities Purchase Agreement
Intensity Therapeutics, Inc. ( ($INTS) ) has provided an announcement. On Octob...
11-01 05:18
Catalyst Watch - Tesla holder vote on Musk pay; AMD, Palantir earnings
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - November ...
11-01 03:11
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alphatec Holdings (NASDAQ:ATEC) shares rose 21.7% to $19.88 during Fri...
10-31 20:10
Why Beneficient (BENF) Shares Soared More Than 46% Overnight?
Beneficient shares surged overnight after the company said it regained compliance with two Nasdaq listing requirements.
10-31 15:52
癌症候选药物1/2期临床数据积极，Intensity Therapeutics(INTS.US)股价暴涨395%
生物制药公司Intensity Therapeutics，周四公布其转移性或难治性癌症候选药物INT230-6的1/2期临床试验结果后，股价收盘暴涨近395%。
10-31 08:09
Intensity Therapeutics shares are trading higher after the company announced the publication of its INT230-6 clinical results in eBioMedicine.
Intensity Therapeutics shares are trading higher after the company announced th...
10-30 21:07
